Colorectal liver metastases.
Identifieur interne : 00B808 ( Ncbi/Checkpoint ); précédent : 00B807; suivant : 00B809Colorectal liver metastases.
Auteurs : D. Burke ; T. G. Allen-MershSource :
- Postgraduate Medical Journal [ 0032-5473 ] ; 1996.
Abstract
Each year in the UK, between 12-14,000 people develop liver metastases from colorectal cancer. These metastases will contribute to the death of the patient in about 80% of cases. Treatments aimed at these tumours are best administered when the tumour is small. Current investigative methods allow tumours as small as 0.5 mm to be detected, and should be offered to all colorectal cancer patients at risk of developing liver metastases. Surgery remains the only curative treatment for these tumours, but, unfortunately, only 20% of those who have tumour excision will survive five years. In those patients unsuitable for surgery, chemotherapy with fluoropyrimidines produces the best tumour response. This may be administered systemically or regionally, via a catheter placed within the hepatic artery. The latter approach reduces systemic toxicity, but may produce hepatotoxicity. The results of other forms of systemic chemotherapy currently undergoing clinical trials are awaited. The vast majority of patients will benefit from suitable palliative treatment delivered either locally or systemically. With the wide range of treatments now available for liver metastases, these patients are best assessed in a unit with a special interest in the problem.
Url:
PubMed: 8796208
PubMed Central: 2398547
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 001C83
- to stream Pmc, to step Curation: 001C82
- to stream Pmc, to step Checkpoint: 004254
- to stream Ncbi, to step Merge: 00B808
- to stream Ncbi, to step Curation: 00B808
Links to Exploration step
PMC:2398547Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Colorectal liver metastases.</title>
<author><name sortKey="Burke, D" sort="Burke, D" uniqKey="Burke D" first="D." last="Burke">D. Burke</name>
</author>
<author><name sortKey="Allen Mersh, T G" sort="Allen Mersh, T G" uniqKey="Allen Mersh T" first="T. G." last="Allen-Mersh">T. G. Allen-Mersh</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">8796208</idno>
<idno type="pmc">2398547</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2398547</idno>
<idno type="RBID">PMC:2398547</idno>
<date when="1996">1996</date>
<idno type="wicri:Area/Pmc/Corpus">001C83</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001C83</idno>
<idno type="wicri:Area/Pmc/Curation">001C82</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001C82</idno>
<idno type="wicri:Area/Pmc/Checkpoint">004254</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">004254</idno>
<idno type="wicri:Area/Ncbi/Merge">00B808</idno>
<idno type="wicri:Area/Ncbi/Curation">00B808</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">00B808</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Colorectal liver metastases.</title>
<author><name sortKey="Burke, D" sort="Burke, D" uniqKey="Burke D" first="D." last="Burke">D. Burke</name>
</author>
<author><name sortKey="Allen Mersh, T G" sort="Allen Mersh, T G" uniqKey="Allen Mersh T" first="T. G." last="Allen-Mersh">T. G. Allen-Mersh</name>
</author>
</analytic>
<series><title level="j">Postgraduate Medical Journal</title>
<idno type="ISSN">0032-5473</idno>
<idno type="eISSN">1469-0756</idno>
<imprint><date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Each year in the UK, between 12-14,000 people develop liver metastases from colorectal cancer. These metastases will contribute to the death of the patient in about 80% of cases. Treatments aimed at these tumours are best administered when the tumour is small. Current investigative methods allow tumours as small as 0.5 mm to be detected, and should be offered to all colorectal cancer patients at risk of developing liver metastases. Surgery remains the only curative treatment for these tumours, but, unfortunately, only 20% of those who have tumour excision will survive five years. In those patients unsuitable for surgery, chemotherapy with fluoropyrimidines produces the best tumour response. This may be administered systemically or regionally, via a catheter placed within the hepatic artery. The latter approach reduces systemic toxicity, but may produce hepatotoxicity. The results of other forms of systemic chemotherapy currently undergoing clinical trials are awaited. The vast majority of patients will benefit from suitable palliative treatment delivered either locally or systemically. With the wide range of treatments now available for liver metastases, these patients are best assessed in a unit with a special interest in the problem.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><label>Figure 1</label>
<graphic xlink:href="postmedj00020-0019-a" xlink:role="465"></graphic>
</fig>
<fig id="F2"><label>Figure 2</label>
<graphic xlink:href="postmedj00020-0019-b" xlink:role="465"></graphic>
</fig>
<fig id="F3"><label>Figure 4</label>
<graphic xlink:href="postmedj00020-0020-a" xlink:role="466"></graphic>
</fig>
<fig id="F4"><label>Figure 5</label>
<graphic xlink:href="postmedj00020-0020-b" xlink:role="466"></graphic>
</fig>
<fig id="F5"><label>Figure 6</label>
<graphic xlink:href="postmedj00020-0021-a" xlink:role="467"></graphic>
</fig>
<fig id="F6"><label>Figure 7</label>
<graphic xlink:href="postmedj00020-0021-b" xlink:role="467"></graphic>
</fig>
</sec>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Allen Mersh, T G" sort="Allen Mersh, T G" uniqKey="Allen Mersh T" first="T. G." last="Allen-Mersh">T. G. Allen-Mersh</name>
<name sortKey="Burke, D" sort="Burke, D" uniqKey="Burke D" first="D." last="Burke">D. Burke</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B808 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 00B808 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= PMC:2398547 |texte= Colorectal liver metastases. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:8796208" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |